Graham K. Cooper, CFO and Treasurer at Orexigen Therapeutics, Inc. (OREX), sold 4,000 shares at $14.13 ($56K) on 2007-12-20, disclosed to the SEC on 2007-12-21.
Scheduled sale ($56k) by CFO and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.05 | 444 | $6K | 11.1% |
| 2 | $14.06 | 421 | $6K | 10.5% |
| 3 | $14.07 | 436 | $6K | 10.9% |
| 4 | $14.08 | 444 | $6K | 11.1% |
| 5 | $14.09 | 412 | $6K | 10.3% |
| 6 | $14.10 | 1,110 |
| $16K |
| 27.8% |
| 7 | $14.11 | 67 | $945 | 1.7% |
| 8 | $14.12 | 90 | $1K | 2.3% |
| 9 | $14.13 | 88 | $1K | 2.2% |
| 10 | $14.14 | 44 | $622 | 1.1% |
| 11 | $14.15 | 444 | $6K | 11.1% |
| Total | $14.09 avg | 4,000 | $56K | 100% |
| Filing → |
| RCPT | SELL | 2014-09-17 | $3.1M | — | Filing → |
| OREX | SELL | 2009-12-23 | $678K | — | Filing → |
| OREX | SELL | 2009-12-23 | $147K | — | Filing → |